HTG Molecular Diagnostics, Inc.
HTGMQ · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $3 | $12 | $3 | $6 |
| + Debt | $4 | $8 | $6 | $9 |
| Enterprise Value | $1 | -$4 | $3 | $4 |
| Revenue | $1 | $2 | $1 | $1 |
| % Growth | -57.7% | 95% | -16.1% | – |
| Gross Profit | -$0 | $0 | $1 | $0 |
| % Margin | -11.3% | 16.7% | 46.4% | 32% |
| EBITDA | -$5 | -$4 | -$4 | -$5 |
| % Margin | -467.6% | -181.2% | -334.2% | -367.2% |
| Net Income | -$5 | -$5 | -$5 | -$6 |
| % Margin | -489.6% | -192.4% | -361% | -394.8% |
| EPS Diluted | -2.28 | -2.12 | -4.91 | -6.42 |
| % Growth | -7.5% | 56.8% | 23.5% | – |
| Operating Cash Flow | -$4 | -$2 | -$5 | -$6 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$2 | -$5 | -$6 |